期刊
EUROPEAN JOURNAL OF IMMUNOLOGY
卷 39, 期 5, 页码 1252-1259出版社
WILEY-BLACKWELL
DOI: 10.1002/eji.200839152
关键词
Anti-tumor immunity; Autoimmunity; CD4(+) T cells; Cytokines; Vaccination
类别
资金
- Canadian Institutes of Health Research [MOP-67066]
- Ontario Cancer Research Network
Previous reports have suggested that autoimmune sequelae may be an unavoidable consequence of successful immunization against tumor-associated antigens, which are typically non-mutated self-antigens. Using a melanoma model, we demonstrated that CD4(+) T-cell-mediated anti-tumor immunity and autoimmunity could be separated by modulating the STAT4/STAT6 signaling axis. Our results have revealed an unexpected dichotomy in the effector phase following cancer vaccination where anti-tumor immunity is mediated via a STAT6 and IL-4-dependent pathway, whereas autoimmune pathology is mediated via STAT4 through a mechanism that relies partially on IFN-gamma. Our results offer a possibility to elicit specific anti-tumor responses without triggering unwanted tissue autoimmune diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据